The DOI matches its Crossref record; 239 of the 239 references it cites were found in a registry or an index.
Cardiovascular Function and Treatment in β-Thalassemia Major: A Consensus Statement From the American Heart Association
Open accessAbstract
This aim of this statement is to report an expert consensus on the diagnosis and treatment of cardiac dysfunction in β-thalassemia major (TM). This consensus statement does not cover other hemoglobinopathies, including thalassemia intermedia and sickle cell anemia, in which a different spectrum of cardiovascular complications is typical. There are considerable uncertainties in this field, with a few randomized controlled trials relating to treatment of chronic myocardial siderosis but none relating to treatment of acute heart failure. The principles of diagnosis and treatment of cardiac iron loading in TM are directly relevant to other iron-overload conditions, including in particular Diamond-Blackfan anemia, sideroblastic anemia, and hereditary hemochromatosis. Heart failure is the most common cause of death in TM and primarily results from cardiac iron accumulation. The diagnosis of ventricular dysfunction in TM patients differs from that in nonanemic patients because of the cardiovascular adaptation to chronic anemia in non–cardiac-loaded TM patients, which includes resting tachycardia, low blood pressure, enlarged end-diastolic volume, high ejection fraction, and high cardiac output. Chronic anemia also leads to background symptomatology such as dyspnea, which can mask the clinical diagnosis of cardiac dysfunction. Central to early identification of cardiac iron overload in TM is the estimation of cardiac iron by cardiac T2* magnetic resonance. Cardiac T2* <10 ms is the most important predictor of development of heart failure. Serum ferritin and liver iron concentration are not adequate surrogates for cardiac iron measurement. Assessment of cardiac function by noninvasive techniques can also be valuable clinically, but serial measurements to establish trends are usually required because interpretation of single absolute values is complicated by the abnormal cardiovascular hemodynamics in TM and measurement imprecision. Acute decompensated heart failure is a medical emergency and requires urgent consultation with a center with expertise in its management. The first principle of management of acute heart failure is control of cardiac toxicity related to free iron by urgent commencement of a continuous, uninterrupted infusion of high-dose intravenous deferoxamine, augmented by oral deferiprone. Considerable care is required to not exacerbate cardiovascular problems from overuse of diuretics or inotropes because of the unusual loading conditions in TM. The current knowledge on the efficacy of removal of cardiac iron by the 3 commercially available iron chelators is summarized for cardiac iron overload without overt cardiac dysfunction. Evidence from well-conducted randomized controlled trials shows superior efficacy of deferiprone versus deferoxamine, the superiority of combined deferiprone with deferoxamine versus deferoxamine alone, and the equivalence of deferasirox versus deferoxamine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–239 of 239
Link, G., Pinson, A., & Hershko, C. (1994) · Blood · doi:10.1182/blood.v83.9.2692.2692 · Cited by 41
Smith, G. C., Alpendurada, F., Carpenter, J. P., Alam, M. H., Berdoukas, V., Karagiorga, M., Ladis, V., Piga, A. G., Aessopos, A., Gotsis, E. D., et al. (2011) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-13-34 · Cited by 41
Self-citationAcute interstitial nephritis due to deferasirox: a case report
Brosnahan, G., Gökden, N., & Swaminathan, S. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn423 · Cited by 41
Intravenous magnesium for cardiac arrhythmias: jack of all trades.
Ho, K. M. (2008) · PubMed · Cited by 40
Kattamis, A., Kassou, C., Berdousi, H., Ladis, V. A., Papassotiriou, I., & KATTAMIS, C. A. (2003) · PubMed · Cited by 40
Alpendurada, F., Smith, G. C., Carpenter, J., Nair, S. V., Tanner, M. A., BANYA, W. A. S., Dessì, C., Galanello, R., Walker, J. M., & Pennell, D. J. (2012) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-14-8 · Cited by 38
Self-citationMaggio, A., Vitrano, A., Lucania, G., Capra, M., Cuccia, L., Gagliardotto, F., Pitrolo, L., Prossomariti, L., Filosa, A., Caruso, V., et al. (2012) · American Journal of Hematology · doi:10.1002/ajh.23219 · Cited by 36
Interdependence of cardiac iron and calcium in a murine model of iron overload
Otto‐Duessel, M., Brewer, C., & Wood, J. C. (2010) · Translational research · doi:10.1016/j.trsl.2010.11.002 · Cited by 36
Self-citationImprovement of Cardiac Function in Thalassemia major Treated with L-Carnitine
El-Beshlawy, A. M., Ragab, L., Fattah, A. A., Youssry, I., Hamdy, M. M., Makhlouf, A., Aoun, E. G., Hoffbrand, V., & Taher, A. T. (2004) · Acta Haematologica · doi:10.1159/000076522 · Cited by 33
Delaporta, P., Kattamis, A. C., Apostolakou, F., Boiu, S., Bartzeliotou, Α., Tsoukas, E., & Papassotiriou, I. (2012) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2012.09.002 · Cited by 31
Seldrum, S., Piérard, S., Moniotte, S., Vermeylen, C., Vancraeynest, D., Pasquet, A., Vanoverschelde, J., & Gerber, B. L. (2011) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-13-23 · Cited by 31
Effect of deferasirox (ICL670) on arterial function in patients with beta‐thalassaemia major
Cheung, Y., Chan, G., & Ha, S. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07092.x · Cited by 30
Poomthavorn, P., Isaradisaikul, B., Chuansumrit, A., Khlairit, P., Sriphrapradang, A., & Mahachoklertwattana, P. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0205 · Cited by 30
Pardalos, G., Kanakoudi-Tsakalidis, F., Malaka-Zafiriu, M., Tsantali, H., Athanasiou-Metaxa, M., Kallinikos, G., & PAPAEVANGELOU, G. J. (1987) · PubMed Central · Cited by 29
Hyperchloremic Metabolic Acidosis Due to Deferasirox in a Patient with Beta Thalassemia Major
Papadopoulos, N., Aresti, V., Aloizos, G., Tapinis, P., & Kikilas, A. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1m440 · Cited by 29
Meloni, A., Detterich, J. A., Berdoukas, V., Pepe, A., Lombardi, M., Coates, T. D., & Wood, J. C. (2012) · American Journal of Hematology · doi:10.1002/ajh.23376 · Cited by 28
Self-citationTestosterone Deficiency and Exercise Intolerance in Heart Failure: Treatment Implications
Iellamo, F., Rosano, G. M. C., & Volterrani, M. (2010) · Current Heart Failure Reports · doi:10.1007/s11897-010-0008-6 · Cited by 28
Carpenter, J., Alpendurada, F., Deac, M., Maceira, A. M., Garbowski, M., Kirk, P., Walker, J. M., Porter, J. B., Shah, F., BANYA, W. A. S., et al. (2010) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-12-24 · Cited by 27
Self-citationThe pituitary–adrenal axis in adult thalassaemic patients
Scacchi, M., Danesi, L., Cattaneo, A., Valassi, E., Giraldi, F. P., Radaelli, P., Ambrogio, A. G., D’Angelo, E., Mirra, N., Zanaboni, L., et al. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0646 · Cited by 27
Cardiovascular involvement in patients with β-thalassemia major without cardiac iron overload
Stakos, D., Margaritis, D., Tziakas, D. N., Kotsianidis, Ι., Chalikias, G. K., Tsatalas, K., Bourikas, G., & Boudoulas, H. K. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.01.047 · Cited by 27
Management of malignant ventricular arrhythmias and cardiac arrest
Fogel, R. I., & Prystowsky, E. N. (2000) · Critical Care Medicine · doi:10.1097/00003246-200010001-00009 · Cited by 27
A synopsis of current care of thalassaemia major patients in Hong Kong.
Au, W. Y., Lee, V., Lau, C. W., Yau, J., Chan, D., Chan, E. Y. T., Cheung, W. W. W., Ha, S., Kho, B., Lee, C., et al. (2011) · PubMed · Cited by 26
Fertility potential in thalassemia major women: current findings and future diagnostic tools
Singer, S. T., Sweeters, N., Vega, O., Higa, A., Vichinsky, E. P., & Cedars, M. I. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05583.x · Cited by 24
Ferric iron uptake into cardiomyocytes of β-thalassemic mice is not through calcium channels
Kumfu, S., Chattipakorn, S. C., Fucharoen, S., & Chattipakorn, N. (2012) · Drug and Chemical Toxicology · doi:10.3109/01480545.2012.726625 · Cited by 24
Bozdoğan, G., Eralp, E. E., Demirel, G. Y., & Yildirmak, Y. (2010) · Pediatric Hematology and Oncology · doi:10.3109/08880018.2010.503334 · Cited by 24
Puskarich, M. A., Runyon, M. S., Trzeciak, S., Kline, J. A., & Jones, A. E. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009334375 · Cited by 23
Heart Disease in Thalassemia Intermedia
Aessopos, A., Tsironi, M., Andreopoulos, A., & Farmakis, D. T. (2009) · Hemoglobin · doi:10.3109/03630260903351676 · Cited by 23
Tavecchia, L., Masera, N., Russo, P., Cirò, A., Vincenzi, A., Vimercati, C., & Masera, G. (2006) · PubMed · Cited by 22
SURVIVING WITH THALASSEMIA MAJOR: The Italian Experience
Borgna‐Pignatti, C. (2006) · Pediatric Hematology and Oncology · doi:10.1080/08880010601001461 · Cited by 22
Atrial dysfunction as a marker of iron cardiotoxicity in thalassemia major
Li, W., Coates, T. D., & Wood, J. C. (2008) · Haematologica · doi:10.3324/haematol.11958 · Cited by 22
Self-citationEffect of L-carnitine on the physical fitness of thalassemic patients
El-Beshlawy, A. M., Accaoui, R. N. E., El-Sattar, M. A., El-Deen, M. H. G., Youssry, I., Shaheen, N., Hamdy, M. M., El-Ghamrawy, M., & Taher, A. T. (2006) · Annals of Hematology · doi:10.1007/s00277-006-0181-6 · Cited by 19
Kwiatkowski, J. L. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2009.11.001 · Cited by 18
Flanagan, J. M., Steward, S. A., Hankins, J. S., Howard, T. M., Neale, G. A. M., & Ware, R. E. (2009) · American Journal of Hematology · doi:10.1002/ajh.21407 · Cited by 18
Thomas, A. S., Garbowski, M., Ang, A. L., Shah, F., Walker, J. M., Moon, J., Pennell, D. J., & Porter, J. B. (2010) · Blood · doi:10.1182/blood.v116.21.1011.1011 · Cited by 17
Self-citationImpaired oxygen kinetics in beta‐thalassaemia major patients
Vasileiadis, I., Roditis, P., Dimopoulos, S. K., Ladis, V., Pangalis, G. A., Aessopos, A., & Nanas, S. (2008) · Acta Physiologica · doi:10.1111/j.1748-1716.2008.01937.x · Cited by 16
Congestive Heart Failure and Treatment in Thalassemia Major
Aessopos, A., Kati, M., & Tsironi, M. (2008) · Hemoglobin · doi:10.1080/03630260701680839 · Cited by 13
Exercise capacity and cardiovascular changes in patients with β‐thalassaemia major
Tocco, F., Crisafulli, A., Melis, F., Loviselli, A., Lai, C., & Concu, A. (2006) · Clinical Physiology and Functional Imaging · doi:10.1111/j.1475-097x.2006.00692.x · Cited by 7
Ha, S., Mok, A. S.-P., Chu, C. W., Rasalkar, D. D., Cheuk, D. K., Chiang, A., Ho, M., & Chan, G. (2009) · Hemoglobin · doi:10.3109/03630260903211979 · Cited by 7
Is Deferasirox Implicated in Multiple Organ Failure in a Patient With Homozygous β-Thalassemia?
Vlachaki, E., Chatzinikolaou, K., Bekiari, E., Klonizakis, P., & Τσάπας, Α. (2011) · Angiology · doi:10.1177/0003319710394160 · Cited by 6
Cited by
Messroghli, D. R., Moon, J. C., Ferreira, V. M., Grosse-Wortmann, L., He, T., Kellman, P., Mascherbauer, J., Nezafat, R., Salerno, M., Schelbert, E. B., et al. (2016) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-017-0389-8 · Cited by 1,727
Normal values for cardiovascular magnetic resonance in adults and children
Kawel-Boehm, N., Maceira, A., Valsangiacomo-Buechel, E. R., Vogel-Claussen, J., Turkbey, E. B., Williams, R., Plein, S., Tee, M., Eng, J., & Bluemke, D. A. (2015) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-015-0111-7 · Cited by 746
Kawel-Boehm, N., Hetzel, S. J., Ambale-Venkatesh, B., Captur, G., Francois, C. J., Jerosch-Herold, M., Salerno, M., Teague, S. D., Valsangiacomo-Buechel, E., van der Geest, R. J., et al. (2020) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-020-00683-3 · Cited by 610
Overview of iron metabolism in health and disease
Dev, S., & Babitt, J. L. (2017) · Hemodialysis International · doi:10.1111/hdi.12542 · Cited by 462
Lipshultz, S. E., Law, Y. M., Asante-Korang, A., Austin, E. D., Dipchand, A. I., Everitt, M. D., Hsu, D. T., Lin, K. Y., Price, J. F., Wilkinson, J. D., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000682 · Cited by 416
Metadata
- Authors
- Pennell, D. J., Udelson, J. E., Arai, A. E., Bozkurt, B., Cohen, A. R., Galanello, R., Hoffman, T. M., Kiernan, M. S., Lerakis, S., Piga, A., Porter, J. B., Walker, J. M., & Wood, J.
- Venue
- Circulation
- Published
- 2013-07-16
- Volume
- 128
- Issue
- 3
- Pages
- 281-308
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1983799237
- Cited by
- 394
- References
- 239
- FWCI
- 11.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.